Cargando…

New horizons in human sperm selection for assisted reproduction

Male infertility is a commonly encountered pathology that is estimated to be a contributory factor in approximately 50% of couples seeking recourse to assisted reproductive technologies. Upon clinical presentation, such males are commonly subjected to conventional diagnostic andrological practices t...

Descripción completa

Detalles Bibliográficos
Autores principales: Nixon, Brett, Schjenken, John E., Burke, Nathan D., Skerrett-Byrne, David A., Hart, Hanah M., De Iuliis, Geoffry N., Martin, Jacinta H., Lord, Tessa, Bromfield, Elizabeth G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9992892/
https://www.ncbi.nlm.nih.gov/pubmed/36909306
http://dx.doi.org/10.3389/fendo.2023.1145533
_version_ 1784902420120207360
author Nixon, Brett
Schjenken, John E.
Burke, Nathan D.
Skerrett-Byrne, David A.
Hart, Hanah M.
De Iuliis, Geoffry N.
Martin, Jacinta H.
Lord, Tessa
Bromfield, Elizabeth G.
author_facet Nixon, Brett
Schjenken, John E.
Burke, Nathan D.
Skerrett-Byrne, David A.
Hart, Hanah M.
De Iuliis, Geoffry N.
Martin, Jacinta H.
Lord, Tessa
Bromfield, Elizabeth G.
author_sort Nixon, Brett
collection PubMed
description Male infertility is a commonly encountered pathology that is estimated to be a contributory factor in approximately 50% of couples seeking recourse to assisted reproductive technologies. Upon clinical presentation, such males are commonly subjected to conventional diagnostic andrological practices that rely on descriptive criteria to define their fertility based on the number of morphologically normal, motile spermatozoa encountered within their ejaculate. Despite the virtual ubiquitous adoption of such diagnostic practices, they are not without their limitations and accordingly, there is now increasing awareness of the importance of assessing sperm quality in order to more accurately predict a male’s fertility status. This realization raises the important question of which characteristics signify a high-quality, fertilization competent sperm cell. In this review, we reflect on recent advances in our mechanistic understanding of sperm biology and function, which are contributing to a growing armory of innovative approaches to diagnose and treat male infertility. In particular we review progress toward the implementation of precision medicine; the robust clinical adoption of which in the setting of fertility, currently lags well behind that of other fields of medicine. Despite this, research shows that the application of advanced technology platforms such as whole exome sequencing and proteomic analyses hold considerable promise in optimizing outcomes for the management of male infertility by uncovering and expanding our inventory of candidate infertility biomarkers, as well as those associated with recurrent pregnancy loss. Similarly, the development of advanced imaging technologies in tandem with machine learning artificial intelligence are poised to disrupt the fertility care paradigm by advancing our understanding of the molecular and biological causes of infertility to provide novel avenues for future diagnostics and treatments.
format Online
Article
Text
id pubmed-9992892
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-99928922023-03-09 New horizons in human sperm selection for assisted reproduction Nixon, Brett Schjenken, John E. Burke, Nathan D. Skerrett-Byrne, David A. Hart, Hanah M. De Iuliis, Geoffry N. Martin, Jacinta H. Lord, Tessa Bromfield, Elizabeth G. Front Endocrinol (Lausanne) Endocrinology Male infertility is a commonly encountered pathology that is estimated to be a contributory factor in approximately 50% of couples seeking recourse to assisted reproductive technologies. Upon clinical presentation, such males are commonly subjected to conventional diagnostic andrological practices that rely on descriptive criteria to define their fertility based on the number of morphologically normal, motile spermatozoa encountered within their ejaculate. Despite the virtual ubiquitous adoption of such diagnostic practices, they are not without their limitations and accordingly, there is now increasing awareness of the importance of assessing sperm quality in order to more accurately predict a male’s fertility status. This realization raises the important question of which characteristics signify a high-quality, fertilization competent sperm cell. In this review, we reflect on recent advances in our mechanistic understanding of sperm biology and function, which are contributing to a growing armory of innovative approaches to diagnose and treat male infertility. In particular we review progress toward the implementation of precision medicine; the robust clinical adoption of which in the setting of fertility, currently lags well behind that of other fields of medicine. Despite this, research shows that the application of advanced technology platforms such as whole exome sequencing and proteomic analyses hold considerable promise in optimizing outcomes for the management of male infertility by uncovering and expanding our inventory of candidate infertility biomarkers, as well as those associated with recurrent pregnancy loss. Similarly, the development of advanced imaging technologies in tandem with machine learning artificial intelligence are poised to disrupt the fertility care paradigm by advancing our understanding of the molecular and biological causes of infertility to provide novel avenues for future diagnostics and treatments. Frontiers Media S.A. 2023-02-22 /pmc/articles/PMC9992892/ /pubmed/36909306 http://dx.doi.org/10.3389/fendo.2023.1145533 Text en Copyright © 2023 Nixon, Schjenken, Burke, Skerrett-Byrne, Hart, De Iuliis, Martin, Lord and Bromfield https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Nixon, Brett
Schjenken, John E.
Burke, Nathan D.
Skerrett-Byrne, David A.
Hart, Hanah M.
De Iuliis, Geoffry N.
Martin, Jacinta H.
Lord, Tessa
Bromfield, Elizabeth G.
New horizons in human sperm selection for assisted reproduction
title New horizons in human sperm selection for assisted reproduction
title_full New horizons in human sperm selection for assisted reproduction
title_fullStr New horizons in human sperm selection for assisted reproduction
title_full_unstemmed New horizons in human sperm selection for assisted reproduction
title_short New horizons in human sperm selection for assisted reproduction
title_sort new horizons in human sperm selection for assisted reproduction
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9992892/
https://www.ncbi.nlm.nih.gov/pubmed/36909306
http://dx.doi.org/10.3389/fendo.2023.1145533
work_keys_str_mv AT nixonbrett newhorizonsinhumanspermselectionforassistedreproduction
AT schjenkenjohne newhorizonsinhumanspermselectionforassistedreproduction
AT burkenathand newhorizonsinhumanspermselectionforassistedreproduction
AT skerrettbyrnedavida newhorizonsinhumanspermselectionforassistedreproduction
AT harthanahm newhorizonsinhumanspermselectionforassistedreproduction
AT deiuliisgeoffryn newhorizonsinhumanspermselectionforassistedreproduction
AT martinjacintah newhorizonsinhumanspermselectionforassistedreproduction
AT lordtessa newhorizonsinhumanspermselectionforassistedreproduction
AT bromfieldelizabethg newhorizonsinhumanspermselectionforassistedreproduction